Navigation Links
Gene therapy to lower blood pressure just enough

A newly developed virus that introduces a blood pressure-lowering gene into cells and enables that gene to maintain blood pressure at healthy levels for four months promises to take gene therapy for the disorder a step closer to reality, said researchers at Baylor College of Medicine in a report released online in the Proceedings of the National Academy of Sciences.

"High blood pressure is one of the leading causes of death and disability in adults worldwide," said Dr. Bert O'Malley, chair of the BCM department of molecular and cellular biology. "A therapy that could control blood pressure could have important benefits for individuals and for the health of the world's population as well."

The gene in question -- atrial natriuretic peptide or ANP -- promises to control blood pressure through a variety of effects on key areas involved in the problem of hypertension, including the relaxation of smooth muscle cells in blood vessels, increasing the vessels' diameters, and reducing the manner in which the vessels react to agents that can constrict those vessels. ANP also improves the manner in which the kidney eliminates sodium or salt from the body and inhibits other systems, such as the sympathetic nervous system, believed linked to development of high blood pressure.

"This makes ANP an attractive agent for use in treating blood pressure," said O'Malley. "However, its use is limited by the fact that it has such short-lived activity in the blood system."

Its activity is halved 30 seconds after it enters the blood stream.

Gene therapy can make cells generate more ANP. In previous studies, however, this kind of gene reduced blood pressure to dangerously low levels, said O'Malley. Obviously, a method of controlling the gene and the amount of ANP a cell makes was needed.

The special viral vector developed by O'Malley and his colleagues combines a special kind of adenovirus altered so it does not produce disease connected to
'"/>

Source:Baylor College of Medicine


Page: 1 2

Related biology news :

1. Adding Radiation Therapy To Chemotherapy Improves Survival In Patients With High-risk Breast Cancer
2. Columbia research lifts major hurdle to gene therapy for cancer
3. Combination therapy boosts effectiveness of telomere-directed cancer cell death
4. Gene therapy converts dead bone graft to new, living tissue
5. Study identifies predictors of HIV drug resistance in patients beginning triple therapy
6. New imaging method gives early indication if brain cancer therapy is effective, U-M study shows
7. Muscle-targeted gene therapy reverses rare muscular dystrophy in mice
8. New therapy for HIV/AIDS eliminates needles and excessive toxicity
9. New Treatment Rivals Chemotherapy For Lymphoma, Study Finds
10. Gene therapy for Parkinsons disease moves forward in animals
11. Pulsating ultrasound enhances gene therapy for tumors

Post Your Comments:
(Date:11/9/2009)...PRNewswire/ -- CBS Vision, the research division o...m Media Group company, today announced a new resea...ss to the CBS Television City research facility ho...he new venture, which marries the capabilities of ...es, will be called Communications Lab@OMD . ,,...
(Date:11/9/2009)...he hopeful news is that pediatric survival rates h...ewstreatments that enable survival often cause inf...e reached puberty currently have an opportunity to...r treatment, they may have their semen frozen and ...o not produce sperm, although their testicular tis...
(Date:11/9/2009)...ten is publishing a special issue "Beyond the Ori...rate Darwin,s On the Origin of Species which was p...tor and author of the lead article is Dr. Ulrich K...ionary biology at the University of Kassel in Germ...ble free of charge until 30 December 2009 on Sprin...
Breaking Biology News(10 mins):CBS and OMD Partner to Provide the Agency With Access to the Network's Television City Research Facility in Las Vegas 2CBS and OMD Partner to Provide the Agency With Access to the Network's Television City Research Facility in Las Vegas 3CBS and OMD Partner to Provide the Agency With Access to the Network's Television City Research Facility in Las Vegas 4For young boys with cancer, testicular tissue banking may be option to preserve fertility 2For young boys with cancer, testicular tissue banking may be option to preserve fertility 3Recovery Act funds expand studies of stem cell biology 10564 1Recovery Act funds expand studies of stem cell biology 10564 2Attention deficit hyperactivity problems associated with low folate levels in pregnant women 10559 1Beaumont U M Open Study of Drug for Advanced Breast Cancer 60244 1Beaumont U M Open Study of Drug for Advanced Breast Cancer 60244 2Beaumont U M Open Study of Drug for Advanced Breast Cancer 60244 3Beaumont U M Open Study of Drug for Advanced Breast Cancer 60244 4
...ing as more and younger people dye their hair, war...to dermatitis on the face and, in severe cases, fa... of hair dyes currently contain para-phenylenediam...h century, allergic reactions to PPD became such a... in Germany, France, and Sweden. , Current Euro...
...g have found an underlying molecular cause for one...ween deafness and the organization of liquid cryst...in the cochlea of the inner ear, sound waves cause... stimulate hair cells, which then trigger nerve im...archers have now learned that mutations in a prote...
...o treat a range of inflammatory conditions and can...he way aspirin works is not yet fully understood. ... of Biological Chemistry in April, Professor Bryan...ical Research, led a collaborative study that inve...ion of protein synthesis. , "Our research show...
Other Biology News:Scientists identify molecular cause for one form of deafness 2
(Date:11/5/2009)...rence Call on Thursday, November 5, 2009 at 4:30 p...Nov. 5 /PRNewswire-FirstCall/ - OncoGenex Pharmace...AQ: OGXI ) today reported unaudited financial res...eptember 30, 2009 and reviewed the Company,s highl...lowing consolidated results reflect the operations...
(Date:11/5/2009)...OOK, N.Y., Nov. 5 BioSpe...harmaceutical company developing first-in-class co...ncial results for the third quarter ended Septembe...in September of this year, the FDA,s Arthritis Adv... of 12-0, the approval of XIAFLEX(TM) for the trea...
(Date:11/5/2009)...WORTH, Texas, Nov. 5 Wou...d today that it has entered into a Letter of Inten...tual Health Technologies, Inc. (OTC Bulletin Board...000,000 in cash and debt, 4,000,000 shares of WNDM... WNDM on the Veriscrip technology being acquired f...
(Date:11/5/2009)...NT, Calif., Nov. 5 Wafer... leading developer of state-of-the-art genetic ana...ars, Ph.D. has joined the company,s Scientific Adv...ning and commercializing novel molecular diagnosti...d on the development of computational biology syst...
Breaking Biology Technology:OncoGenex Reports Third Quarter 2009 Financial Results 2OncoGenex Reports Third Quarter 2009 Financial Results 3OncoGenex Reports Third Quarter 2009 Financial Results 4OncoGenex Reports Third Quarter 2009 Financial Results 5OncoGenex Reports Third Quarter 2009 Financial Results 6OncoGenex Reports Third Quarter 2009 Financial Results 7OncoGenex Reports Third Quarter 2009 Financial Results 8BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 2BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 3BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 4BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 5OTCBB-WNDM Announces LOI to Acquire VHGI Assets for $10 Million Cash/Stock 2OTCBB-WNDM Announces LOI to Acquire VHGI Assets for $10 Million Cash/Stock 3WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board 2WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board 3WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board 4
...io is designed to work with many different audio d...Ariz. Watch out iPod and Sirius Radio ; here ...s DEMO conference , ,The company introduced a se...io and music files through cell phones in their ca... 700 technology industry insiders, media, and inve...
...gital optical modules, designed to sample high-ene...deployed in 70 deep holes in the Antarctic ice. Ph... Wis. Working under harsh Antarctic conditions, ... technicians has set in place the first critical e...th Pole. , ,The successful deployment - in a 1.5 m...
...Wis. The Wisconsin Alumni Research Foundation ,... of Wisconsin-Madison, will be among the recipient...rch 15 at a White House ceremony. The annual award...standing contributions to the Nations economic, e...velopment and commercialization of technology prod...
Other Biology Technology:Motorola debuts iRadio for anywhere, anytime music 2First pieces of Antarctic deep-space particle detector are in place 2First pieces of Antarctic deep-space particle detector are in place 3First pieces of Antarctic deep-space particle detector are in place 4First pieces of Antarctic deep-space particle detector are in place 5
Rabbit Anti-FOXJ2 Polyclonal Antibody, Unconjugated from Abcam
PI/RNase Staining Buffer Solution from BD Biosciences Pharmingen
Goat Anti-HSPC150 Polyclonal Antibody, Unconjugated from Abcam
Rabbit Anti-Human Macrophage-stimulating protein receptor Polyclonal Antibody, Unconjugated from GenWay Biotech, Inc.
Biology Products: